Preface |
|
ix | |
Acknowledgements |
|
ix | |
Author biographies |
|
x | |
Abbreviations |
|
xi | |
|
Chapter 1 The nature of diabetes |
|
|
1 | (11) |
|
|
1 | (6) |
|
|
7 | (2) |
|
Clinical presentations of diabetes |
|
|
9 | (1) |
|
Complications of diabetes |
|
|
9 | (1) |
|
|
10 | (2) |
|
Chapter 2 Glucose, insulin, and diabetes |
|
|
12 | (13) |
|
The role and regulation of glucose |
|
|
12 | (6) |
|
The role and regulation of insulin |
|
|
18 | (7) |
|
Chapter 3 Type 1 diabetes |
|
|
25 | (9) |
|
|
25 | (1) |
|
Causes of type 1 diabetes |
|
|
26 | (5) |
|
Development of type 1 diabetes |
|
|
31 | (1) |
|
|
31 | (1) |
|
Screening for potential type 1 diabetes |
|
|
32 | (2) |
|
Chapter 4 Type 2 diabetes |
|
|
34 | (15) |
|
|
34 | (1) |
|
Causes of type 2 diabetes |
|
|
35 | (2) |
|
|
37 | (3) |
|
Metabolic syndrome and obesity |
|
|
40 | (2) |
|
Development of type 2 diabetes |
|
|
42 | (2) |
|
|
44 | (1) |
|
|
44 | (1) |
|
Glucotoxicity and lipotoxicity |
|
|
45 | (1) |
|
|
46 | (3) |
|
Chapter 5 Diabetes screening and patient care |
|
|
49 | (15) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
50 | (1) |
|
Screening for complications |
|
|
50 | (2) |
|
|
52 | (4) |
|
The elderly person with diabetes |
|
|
56 | (2) |
|
|
58 | (1) |
|
Patient education and community care |
|
|
59 | (1) |
|
|
60 | (4) |
|
Chapter 6 Diabetes and vascular disease |
|
|
64 | (21) |
|
|
64 | (1) |
|
Pathogenesis of macrovascular complications |
|
|
65 | (1) |
|
Treatment and management principles for macrovascular disease |
|
|
66 | (1) |
|
Glucose-lowering drugs and cardiovascular disease |
|
|
67 | (6) |
|
|
73 | (1) |
|
Pathogenesis of microvascular complications |
|
|
73 | (4) |
|
Treatment and management principles for microvascular disease |
|
|
77 | (1) |
|
Reducing the risk of vascular disease |
|
|
78 | (7) |
|
Chapter 7 Diabetic neuropathy |
|
|
85 | (10) |
|
Prevalence and classification |
|
|
85 | (1) |
|
|
86 | (1) |
|
Chronic sensory polyneuropathy |
|
|
87 | (2) |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
90 | (2) |
|
|
92 | (3) |
|
Chapter 8 Diabetic eye disease |
|
|
95 | (8) |
|
|
95 | (1) |
|
|
95 | (1) |
|
Nonproliferative diabetic retinopathy |
|
|
96 | (2) |
|
Proliferative diabetic retinopathy |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
100 | (3) |
|
Chapter 9 Diabetic kidney disease |
|
|
103 | (15) |
|
|
103 | (1) |
|
|
103 | (3) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
107 | (1) |
|
Newer glucose-lowering drugs in diabetic kidney disease |
|
|
108 | (7) |
|
Renal replacement therapy |
|
|
115 | (2) |
|
Pancreas transplant or islet cell implantation |
|
|
117 | (1) |
|
Chapter 10 Skin and musculoskeletal complications of diabetes |
|
|
118 | (18) |
|
Skin manifestations of diabetes |
|
|
118 | (6) |
|
Musculoskeletal conditions associated with diabetes |
|
|
124 | (4) |
|
|
128 | (6) |
|
|
134 | (2) |
|
Chapter 11 Infections and diabetes |
|
|
136 | (10) |
|
|
136 | (1) |
|
|
136 | (1) |
|
|
137 | (7) |
|
|
144 | (1) |
|
Glycemic control and infection outcomes |
|
|
145 | (1) |
|
Chapter 12 Severe diabetic metabolic disturbances |
|
|
146 | (11) |
|
|
146 | (4) |
|
|
150 | (3) |
|
Hyperosmolar hyperglycemic state or hyper-osmolar nonketotic state |
|
|
153 | (2) |
|
Brittle diabetes mellitus |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
156 | (1) |
|
Chapter 13 Long-term management of hyperglycemia |
|
|
157 | (9) |
|
|
157 | (1) |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (2) |
|
Remission of type 2 diabetes |
|
|
164 | (2) |
|
Chapter 14 Noninsulin therapies |
|
|
166 | (15) |
|
|
166 | (1) |
|
|
167 | (11) |
|
|
178 | (3) |
|
Chapter 15 Insulin treatment and pancreatic/islet cell transplantation |
|
|
181 | (24) |
|
|
181 | (1) |
|
Indications for insulin treatment |
|
|
181 | (1) |
|
|
182 | (2) |
|
|
184 | (2) |
|
Insulin regimen: type 1 diabetes |
|
|
186 | (4) |
|
Continuous glucose monitors (CGMs) |
|
|
190 | (1) |
|
Insulin regimen: type 2 diabetes |
|
|
191 | (4) |
|
Metabolic instability on insulin |
|
|
195 | (1) |
|
Complications: hypoglycemia |
|
|
196 | (3) |
|
|
199 | (1) |
|
Other complications or adverse effects from insulin treatment |
|
|
200 | (1) |
|
|
201 | (1) |
|
|
202 | (3) |
|
Chapter 16 Special management considerations |
|
|
205 | (15) |
|
Inpatient diabetes considerations |
|
|
205 | (1) |
|
|
206 | (2) |
|
Conception, contraception, and pregnancy |
|
|
208 | (9) |
|
|
217 | (3) |
References |
|
220 | (8) |
Resources: Research and support organizations |
|
228 | (2) |
Glossary |
|
230 | (8) |
Index |
|
238 | |